Jennifer L Smith1, Steven Estus2, Terry A Lennie1, Debra K Moser3, Misook L Chung1, Gia Mudd-Martin1. 1. College of Nursing, University of Kentucky, Lexington, KY, USA. 2. Department of Physiology and Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA. 3. Linda C. Gill Endowed Chair of Nursing, College of Nursing, University of Kentucky, Lexington, KY, USA.
Abstract
INTRODUCTION: A heart-healthy diet might reduce cardiovascular disease (CVD) risk. Genetic variants that affect taste are associated with food choices. This study aims to investigate the associations of the TAS2R38 haplotype with consumption of sodium, sugar, saturated fats, and vegetables. HYPOTHESIS: We hypothesized that, compared to people who are alanine-valine-isoleucine (AVI) homozygous for the TAS2R38 gene, those who are heterozygous or homozygous for the proline-alanine-valine (PAV) haplotype would have (a) a higher intake of sodium, sugar, and saturated fat, and (b) a lower vegetable intake. METHODS: DNA from participants at risk for CVD was genotyped, and participants were assigned to groups by haplotype. Intake for sodium, sugar, saturated fat, and vegetables was assessed using the Viocare Food Frequency Questionnaire. Intake was categorized as higher versus lower consumption, divided at the median, and examined by logistic regressions. All models controlled for age, sex, smoking status, body mass index, education level, and financial status. RESULTS: The 175 participants had a mean age of 52 ± 13 years, 72.6% were female, 100% were Caucasian, 89.1% were overweight or obese, and 82.9% were nonsmokers. Participants with one or two PAVs were grouped together, as PAV is the dominant gene, and comprised a majority of the sample (80.6%). Haplotype did not predict intake of sodium, sugar, or saturated fats. Compared to AVI homozygotes, participants with PAV homozygous or heterozygous haplotype had lower odds of being in the higher vegetable intake group (95% CI [0.17, 0.92], p = .032). CONCLUSIONS: PAV haplotype predicted lower consumption of vegetables. Variants of taste-related genes appear to play a role in food choices.
INTRODUCTION: A heart-healthy diet might reduce cardiovascular disease (CVD) risk. Genetic variants that affect taste are associated with food choices. This study aims to investigate the associations of the TAS2R38 haplotype with consumption of sodium, sugar, saturated fats, and vegetables. HYPOTHESIS: We hypothesized that, compared to people who are alanine-valine-isoleucine (AVI) homozygous for the TAS2R38 gene, those who are heterozygous or homozygous for the proline-alanine-valine (PAV) haplotype would have (a) a higher intake of sodium, sugar, and saturated fat, and (b) a lower vegetable intake. METHODS: DNA from participants at risk for CVD was genotyped, and participants were assigned to groups by haplotype. Intake for sodium, sugar, saturated fat, and vegetables was assessed using the Viocare Food Frequency Questionnaire. Intake was categorized as higher versus lower consumption, divided at the median, and examined by logistic regressions. All models controlled for age, sex, smoking status, body mass index, education level, and financial status. RESULTS: The 175 participants had a mean age of 52 ± 13 years, 72.6% were female, 100% were Caucasian, 89.1% were overweight or obese, and 82.9% were nonsmokers. Participants with one or two PAVs were grouped together, as PAV is the dominant gene, and comprised a majority of the sample (80.6%). Haplotype did not predict intake of sodium, sugar, or saturated fats. Compared to AVI homozygotes, participants with PAV homozygous or heterozygous haplotype had lower odds of being in the higher vegetable intake group (95% CI [0.17, 0.92], p = .032). CONCLUSIONS:PAV haplotype predicted lower consumption of vegetables. Variants of taste-related genes appear to play a role in food choices.
Authors: Ana P Nunes; Isabel O Oliveira; Betânia R Santos; Cristini Millech; Liziane P Silva; David A González; Pedro C Hallal; Ana M B Menezes; Cora L Araújo; Fernando C Barros Journal: BMC Med Res Methodol Date: 2012-05-04 Impact factor: 4.615
Authors: Jean E Abraham; Mel J Maranian; Inmaculada Spiteri; Roslin Russell; Susan Ingle; Craig Luccarini; Helena M Earl; Paul P D Pharoah; Alison M Dunning; Carlos Caldas Journal: BMC Med Genomics Date: 2012-05-30 Impact factor: 3.063